Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -34.95% |
| Q3 2025 | 46.48% |
| Q2 2025 | 25.08% |
| Q1 2025 | -22.31% |
| Q4 2024 | -10.09% |
| Q3 2024 | 674.00% |
| Q2 2024 | -89.41% |
| Q1 2024 | 74.01% |
| Q4 2023 | -17.28% |
| Q3 2023 | 3.18% |
| Q2 2023 | -23.54% |
| Q1 2023 | -24.13% |
| Q4 2022 | 222.31% |
| Q3 2022 | 18.40% |
| Q2 2022 | -79.04% |
| Q1 2022 | -11.62% |
| Q4 2021 | -32.40% |
| Q3 2021 | 585.99% |
| Q2 2021 | -13.56% |
| Q1 2021 | -48.28% |
| Q4 2020 | 362.48% |
| Q3 2020 | -150.09% |
| Q2 2020 | 54.10% |
| Q1 2020 | -18.58% |
| Q4 2019 | 48.85% |
| Q3 2019 | 364.89% |
| Q2 2019 | -88.61% |
| Q1 2019 | 27.89% |
| Q4 2018 | 85.55% |
| Q3 2018 | 22.68% |
| Q2 2018 | -47.61% |
| Q1 2018 | 17.44% |
| Q4 2017 | 29.32% |
| Q3 2017 | 515.81% |
| Q2 2017 | -127.97% |
| Q1 2017 | 34.30% |
| Q4 2016 | -57.29% |
| Q3 2016 | 104.28% |
| Q2 2016 | 541.02% |
| Q1 2016 | -156.81% |